How Useful Are Pharmacogenomic Decision Support Tools for the Treatment of Bipolar Disorder?

Pharmacogenetic testing may benefit people receiving low-dose lithium in clinical practice

MR Dickerson, J Reed - Journal of the American Association of …, 2023 - journals.lww.com
Background: Mental illnesses are leading causes of disability in the United States. Some
evidence supports that pharmacogenetic testing may be beneficial in select populations and …
相关文章 所有 3 个版本
[PDF] core.ac.uk

[引用][C] Pharmacogenetic Testing to Reduce Depression and Anxiety in Adults Treated with Low-Dose Lithium

MR Dickerson - 2023 - University of Missouri--Kansas City
相关文章 所有 2 个版本